EUVIMEDEUVIMED entdecken
Crossref

Altitude and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in China: A Population-Based Study

Yufei Wang iD, Qiong Meng, Jin Zhang, Bing Guo, Nanyan Li, Qian Deng, Julinling Hu, Quzong Deji, Han Guan, Wangjiu Danzhen, Hui Yu, Zhifeng Li und 1 weitere

High Altitude Medicine & Biology · 01.06.2025 · 26 (2) · 148-155

DOI: 10.1089/ham.2024.0054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift High Altitude Medicine & Biology, online erschienen am 26.05.2025. Verfasst von Yufei Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Altitude, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Yufei Wang, Qiong Meng, Jin Zhang, Bing Guo, Nanyan Li, Qian Deng, Julinling Hu, Quzong Deji, Han Guan, Wangjiu Danzhen, Hui Yu, Zhifeng Li, and Junmin Zhou. Altitude and metabolic dysfunction-associated fatty liver disease (MAFLD) in China: a population-based study. High Alt Med Biol. 26:148–155, 2025.

Objectives

The epidemiological evidence for the relationship between altitude and metabolic dysfunction-associated fatty liver disease (MAFLD) is scarce. This study aims to examine the altitude–MAFLD relationship and explore the potential mediators explaining the relationship.

Methods

Data were derived from the China Multi-Ethnic Cohort. The participants’ altitude information was extracted from their residential addresses. MAFLD was diagnosed based on radiographically confirmed hepatic steatosis and any one of the following three items: overweight/obese status, diabetes mellitus, or metabolic dysregulation. We performed multivariable logistic regression and mediation analyses to assess the altitude–MAFLD associations and potential mediators, respectively. In the mediation analysis, mediation proportion is an estimate of the extent to which the total effect (altitude–MAFLD association) is accounted for by the pathway through the mediators.

Results

In total, 87,679 participants (female: 60.7%, mean age: 51.36 years) were included. The odds ratio of MAFLD was 1.61 (95% confidence interval [CI]: 1.52–1.71) between high and low altitudes, 1.52 (95% CI: 1.43–1.62) between high and middle altitudes, and 1.06 (95% CI: 1.01–1.10) between middle and low altitudes. Of the total estimated effect between high and low altitude, physical activity and vegetable intake accounted for 15.7% (95% CI: 12.8–19.1) and 3.8% (95% CI: 1.2–6.6), respectively. Of the total estimated effect between high and middle altitude, physical activity and vegetable intake accounted for 31.4% (95% CI: 26.2–34.8) and 2.3% (95% CI: 0.6–3.8), respectively. Of the total estimated effect between middle and low altitude, vegetable intake accounted for 11.8% (95% CI: 3.2–61.5).

Conclusion

Higher altitude was associated with increased odds of MAFLD, and physical activity and vegetable intake mediated such association. Multifaceted efforts should be taken in public health to promote healthy lifestyles among higher altitude residents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AltitudeNon-alcoholic Fatty Liver DiseaseFatty LiverHumansFemaleMaleChinaMiddle AgedAdultObesityRisk FactorsOverweightAgedDiabetes MellitusLogistic Models

Stichwörter der Autor:innen

MAFLDaltitudedietmediationphysical activity

Autor:innen und Institutionen

  • West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
  • School of Public Health, Kunming Medical University, Yunnan, China.
  • School of Medicine, Tibet University, Tibet, China.
  • School of Public Health, The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.
  • Tibet Center for Disease Control & Prevention, Tibet, China.
  • Jianyang Center for Disease Control & Prevention, Chengdu, China.

ORCID-Profile: Yufei Wang

Zitieren

APA

Wang, Y., Meng, Q., Zhang, J., Guo, B., Li, N., Deng, Q., Hu, J., Deji, Q., Guan, H., Danzhen, W., Yu, H., Li, Z., & Zhou, J. (2025). Altitude and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in China: A Population-Based Study. High Altitude Medicine & Biology, 26(2), 148-155. https://doi.org/10.1089/ham.2024.0054

Vancouver

Wang Y, Meng Q, Zhang J, Guo B, Li N, Deng Q, et al. Altitude and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in China: A Population-Based Study. High Altitude Medicine & Biology. 2025;26(2):148-155. doi:10.1089/ham.2024.0054

BibTeX
@article{Wang2025,
  author = {Wang, Yufei and Meng, Qiong and Zhang, Jin and Guo, Bing and Li, Nanyan and Deng, Qian and Hu, Julinling and Deji, Quzong and Guan, Han and Danzhen, Wangjiu and Yu, Hui and Li, Zhifeng and Zhou, Junmin},
  title = {Altitude and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in China: A Population-Based Study},
  journal = {High Altitude Medicine & Biology},
  year = {2025},
  volume = {26},
  number = {2},
  pages = {148--155},
  doi = {10.1089/ham.2024.0054}
}
Kostenlos starten →